← Evidence map

ReviewDrug safety2005

Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.

Ann Cranney et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2005
…
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 16048357